经肝动脉化疗栓塞治疗肝癌的疗效分析  

Efficacy of transhepatic artery chemotherapy embolization in the treat ment of primary hepatocellular carc inoma

作　　者：张春[1] 贾雄山[1] 张瑞清[1] 王树江[1] 宁庆楼 王久明[1] 

机构地区：[1]天津蓟县人民医院放射科,天津市301900

出　　处：《实用医学影像杂志》2001年第3期168-170,共3页Journal of Practical Medical Imaging

摘　　要：目的探讨经肝动脉化疗栓塞TACE、单纯灌注化疗TAI治疗原发性肝癌的疗效。材料与方法对32例原发性肝癌中25例行TACE治疗,7例行TAI治疗。结果通过TACE治疗的病例半年、1年、2年生存率分别为70%、56%、32.2%,TAI治疗的病例提高了生存质量。结论TACE治疗原发性肝癌能提高患者的生存质量。延长生存时间。TAI治疗仅能提高生存质量。Objective To assess the efficacy of transcatheler hepatic artery chemotherapy emb olization and single infusion chemotherapy in the treatment of primary hepatocellular carcinoma.Methods Thirty -two patients with primary hepatocellular carcinoma,in whom 25cases underwent transhepatic artery chemotherapy embolization s and 7cases underwent single infusion chemotherapy were inves-tigated in the study.Results The survival rate of 25patients at 0.5,1and 2years after transhepatic artery chemotherapy embolization was70%,50%and 32.2%,respectively.Si ngle infusion chemotherapy also imp roved to some extent the survival quality of part pa-tients.Conclusion Transhepatic artery chemotherapy e mbolization is significanthy super to single infusion chemotherapy in t he treatment of primary hepatocellular carcinoma.[

关 键 词：肝动脉 化疗栓塞 肝癌 疗效 

分 类 号：R735.7[医药卫生—肿瘤]